{"id":"W2169431633","doi":"10.1016/s0140-6736(09)62038-9","title":"Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial","year":2010,"lang":"en","type":"article","venue":"The Lancet","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Allergy and Infectious Diseases; National Institute of Mental Health; National Heart, Lung, and Blood Institute; U.S. Public Health Service","keywords":"Medicine; Placebo; Clinical endpoint; Hazard ratio; Internal medicine; Viral load; Herpes simplex virus; Aciclovir; Gastroenterology; Randomized controlled trial; Immunology; Confidence interval; Virus; Viral disease; Herpesviridae; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000402759,0.0001856537,0.0006681014,0.00006943584,0.000137537,0.00004669076,0.0000717811,0.0000765521,0.0001031088],"category_scores_gemma":[0.0004946606,0.00009547762,0.00007203692,0.000180689,0.00007596905,0.00006661899,0.00002561981,0.000191958,0.00002134238],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002373827,"about_ca_system_score_gemma":0.0001742946,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004338347,"about_ca_topic_score_gemma":0.0006961516,"domain_scores_codex":[0.9989988,0.000103123,0.0002351176,0.0002306227,0.000146559,0.000285755],"domain_scores_gemma":[0.9988912,0.0004213275,0.0001033562,0.0003737683,0.0000692843,0.0001410864],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9676263,0.0006126463,0.01705565,0.0000483615,0.0001881016,0.00002103592,0.0002774786,0.000005830059,0.0004192392,0.00006603733,0.00113174,0.01254759],"study_design_scores_gemma":[0.94772,0.0006432127,0.02740097,0.0000802981,0.0003668712,0.00001084097,0.0000199881,0.0008807344,0.000165209,0.0001241875,0.02244816,0.000139533],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912969,0.00007252724,0.0000525061,0.001631651,0.0001481979,0.00589624,0.00006201731,0.00008489265,0.0007550706],"genre_scores_gemma":[0.9968458,0.00003971846,0.0004678105,0.000222948,0.0005267761,0.001352651,0.00007878182,0.00002830785,0.0004371775],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02131642,"threshold_uncertainty_score":0.3893464,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.015807759422604,"score_gpt":0.3041585563822332,"score_spread":0.2883507969596292,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}